Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma
2012 · Genome Medicine · 36 citations
https://doi.org/10.1186/gm402
Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
262
Citations
7
h-index
5
i10-index
Mitsuhiro Itagaki is an academic researcher from Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Acute Myeloid Leukemia Research & Protein Degradation and Inhibitors. The author has an h-index of 7, co-authored 47 publications.
https://doi.org/10.1186/gm402
https://doi.org/10.1007/s12185-024-03754-8
Click to start Chat